Prevalence of Acanthosis Nigricans in an urban population in Sri Lanka and its utility to detect metabolic syndrome

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Dassanayake, Anuradha S ^a   Kasturiratne, Anuradhani ^a   Niriella, Madunil A ^a   Kalubovila, Udaya ^a   Rajindrajith, Shaman ^a   De Silva, Arjuna P ^a   Kato, Norihiro ^b   Wickremasinghe, A Rajitha ^a   De Silva, H Janaka ^a  

^a UNIVERSITY OF KELANIYA   (Sri Lanka)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79251569576     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-25     Document Type: Article

References (16)

1. Burke JP, Hale DE, Hazuda HP, Stern MP: A quantitative scale of acanthosis nigricans. Diabetes Care 1999, 22(10):1655-9. (Pubitemid 29458388)
2. Stuart CA, Gilkison CR, Smith MM, Bosma AM, Keenan BS, Nagamani M: Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr (Phila) 1998, 37(2):73-9.
3. Stuart CA, Smith MM, Gilkson CR, Shaheb S, Stahn RM: Acanthosis nigricans among Native Americans: an indicator of high diabetes risk. Am J Public Health 1994, 84:1839-42. (Pubitemid 24355657)
4. Gilkson C, Stuart CA: Assessment of patients with acanthosis nigricans skin lesion for hyperinsulinaemia, insulin resistance and diabetes risk. Nurse Pract 1992, 17:26-44.
5. Stuart CA, Pate CJ, Peters EJ: Prevalence of acanthosis nigricans in an unselected population. Am J Med 1989, 87:269-72. (Pubitemid 19234278)
6. Hud JA, Cohen JB, Wagner JM, Cruz PD: Prevalence and significance of acanthosis. nigricans in an adult obese population. Arch Dermatol 1992, 128:941-4.
7. Kong AS, Williams RL, Smith M, Sussman AL, Skipper B, Andrew C, Rhyne RL: Acanthosis Nigricans and diabetes Risk factors: Prevalence in Young persons seen in South Western US primary care practices. Ann Fam Med 2007, 5:202-208. (Pubitemid 46889996)
8. Yamazaki Ito S, Yoshida H: Acanthosis nigricans is a reliable cutaneous marker of insulin resistence in obese Japanese children. Paeditr Int 2003, 45:701-705.
9. Grandhe NP, Bhansali A, Dogra S, Kumar B: Acanthosis nigricans:relation with type 2 diabetes mellitus, antropometric varables, and body mass in Indians. Post Med J 2005, 81:541-544. (Pubitemid 41160601)
10. Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De silva AP, Mizoue T, Makaya M, Wickramasinghe AR, de Silva HJ: Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol 2009, 24:1284-1288.
11. Fan JG, Saibara T, Chitturi S, Asia-Pacific working party for NAFLD: What are the risk factors for non-alcoholic fatty liver disease in Asia-Pacific. J Gastroenterol Hepatol 2007, 22:794-800. (Pubitemid 46911036)
12. Rave GM: Role of insulin resistance in human disease. Diabetes 1988, 37:1595-607.
13. Third report of the National cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel 111) final report. Circulation 2002, 106:3143-421.
14. Murphy E, Minor VE, Neal WA: Metaboilic syndrome in fifth grade children with acanthosis nigricans. World J Paediat 2009, 5:23-30.
15. Jones LH, Ficca M: Is Acanthosis nigricans a reliable indicator for risk of type 2 diabetes? J Sch N 2007, 23:247-51.
16. Stoddast ML, Blevins KS, Lee ET, Wang W, Blackett PR: Association of Acanthosis Nigricans with Hyperinsulinaemia compared with other selected risk factor for type 2 diabetes in Cherokee Indians. Diabetes care 2002, 25(6):1009-1014. (Pubitemid 41110486)